118 related articles for article (PubMed ID: 32331097)
1. Catechin Loaded Poly(lactic-co-glycolic acid) Nanoparticles: Characterization, Antioxidant and Cytotoxic Activity Against MCF-7 Breast Cancer Cells.
Turkoglu B; Mansuroglu B
J Nanosci Nanotechnol; 2020 Sep; 20(9):5313-5321. PubMed ID: 32331097
[TBL] [Abstract][Full Text] [Related]
2. Preparation of Poly[lactic-co-glycolic] Acid Nanospheres and Its Role in Hepatoma Cells.
Shi Z; Li J; Liang H; Hu H; Jiang H
J Nanosci Nanotechnol; 2021 Feb; 21(2):977-986. PubMed ID: 33183433
[TBL] [Abstract][Full Text] [Related]
3. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells.
Sharma A; Hawthorne S; Jha SK; Jha NK; Kumar D; Girgis S; Goswami VK; Gupta G; Singh S; Dureja H; Chellappan DK; Dua K
Nanomedicine (Lond); 2021 Aug; 16(20):1763-1773. PubMed ID: 34296625
[No Abstract] [Full Text] [Related]
4. Synthesis of three-arm block copolymer poly(lactic-
Zhu X; Liu C; Duan J; Liang X; Li X; Sun H; Kong D; Yang J
Int J Nanomedicine; 2016; 11():6065-6077. PubMed ID: 27895480
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
6. QbD enabled optimization of solvent shifting method for fabrication of PLGA-based nanoparticles for promising delivery of Capecitabine for antitumor activity.
Jena GK; Patra CN; Panigrahi KC; Sruti J; Patra P; Parhi R
Drug Deliv Transl Res; 2022 Jun; 12(6):1521-1539. PubMed ID: 34505271
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment.
Saha C; Kaushik A; Das A; Pal S; Majumder D
PLoS One; 2016; 11(5):e0155710. PubMed ID: 27196562
[TBL] [Abstract][Full Text] [Related]
8. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line.
Anari E; Akbarzadeh A; Zarghami N
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1410-6. PubMed ID: 26148177
[TBL] [Abstract][Full Text] [Related]
9. Dual drug loaded PLGA nanospheres for synergistic efficacy in breast cancer therapy.
Deepika MS; Thangam R; Sheena TS; Vimala RTV; Sivasubramanian S; Jeganathan K; Thirumurugan R
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109716. PubMed ID: 31349431
[TBL] [Abstract][Full Text] [Related]
10. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of designed PLGA-arctiin nanoparticles modified with folic acid and chitosan on colon cancer cells.
Alhadidi MHA; Tabrizi MH; Ghobeh M
Biotechnol Appl Biochem; 2024 Feb; 71(1):72-80. PubMed ID: 37817403
[TBL] [Abstract][Full Text] [Related]
12. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
Akhter MH; Kumar S; Nomani S
Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
[No Abstract] [Full Text] [Related]
13. Preparation and characterization of bee venom-loaded PLGA particles for sustained release.
Park MH; Jun HS; Jeon JW; Park JK; Lee BJ; Suh GH; Park JS; Cho CW
Pharm Dev Technol; 2018 Nov; 23(9):857-864. PubMed ID: 27881046
[TBL] [Abstract][Full Text] [Related]
14. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
[TBL] [Abstract][Full Text] [Related]
15. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
16. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
Borah A; Pillai SC; Rochani AK; Palaninathan V; Nakajima Y; Maekawa T; Kumar DS
Nanotechnology; 2020 May; 31(18):185102. PubMed ID: 31952056
[TBL] [Abstract][Full Text] [Related]
17. The remarkable role of emulsifier and chitosan, dextran and PEG as capping agents in the enhanced delivery of curcumin by nanoparticles in breast cancer cells.
Sampath M; Pichaimani A; Kumpati P; Sengottuvelan B
Int J Biol Macromol; 2020 Nov; 162():748-761. PubMed ID: 32585267
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin.
Hafezi Ghahestani Z; Alebooye Langroodi F; Mokhtarzadeh A; Ramezani M; Hashemi M
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):955-960. PubMed ID: 27327450
[TBL] [Abstract][Full Text] [Related]
19. Optimization and characterization of poly(lactic-co-glycolic acid) nanoparticles loaded with astaxanthin and evaluation of anti-photodamage effect
Hu F; Liu W; Yan L; Kong F; Wei K
R Soc Open Sci; 2019 Oct; 6(10):191184. PubMed ID: 31824727
[TBL] [Abstract][Full Text] [Related]
20. Nifedipine-loaded polymeric nanoparticles: Preparation and in vitro characterization.
Ozakar E; Cetin M; Ates O; Hacimuftuoglu A
Pak J Pharm Sci; 2019 Mar; 32(2):547-554. PubMed ID: 31081765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]